Form 4: Abbott Laboratories Executive Vice President Louis H. Morrone Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Executive Vice President Louis H. Morrone reports the disposition of Abbott Laboratories common shares, including those withheld for tax obligations and shares sold on the market.
Summary
- Louis H. Morrone, an Executive Vice President at Abbott Laboratories, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On February 28, 2025, 4,386 common shares were disposed of at a price of $135.87.
- These shares were likely withheld to cover tax obligations.
- On March 3, 2025, 1,111 common shares were sold at a price of $138.17.
- Following these transactions, Morrone directly owns 66,878 common shares.
- Morrone also indirectly owns shares through a Profit Sharing Trust.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, reflecting neutral sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Disposition of 4,386 common shares at $135.87 per share. |
| 03/03/2025 | Sale of 1,111 common shares at $138.17 per share. |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.